Please login to the form below
Riovant Sciences
This page shows the latest Riovant Sciences news and features for those working in and with pharma, biotech and healthcare.
Takeda forms new women's health and cancer company
Myovant Sciences will focus on delivering innovative therapies in the two areas, with former Medivation chief medical officer Lynn Seely appointed to lead the business. ... For its tie-up with Takeda, the Japanese firm has granted Myovant Sciences an
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Moderna to begin pivotal phase 3 trial of COVID-19 vaccine in July
- ASCO: Momentum gathers behind next wave of CAR-T therapies
- Lilly starts world first trial of an antibody drug for COVID-19
- Four European nations form alliance to fast-track COVID-19 vaccine
- ASCO: Momentum gathers behind next wave of CAR-T therapies
- Merck’s Keytruda hits the mark in triple negative breast cancer
- AstraZeneca forges agreements for equal access to COVID-19 vaccine
- Hydroxychloroquine safety study pulled on data integrity concern
- UCB buys epilepsy firm Engage Tx in $270m deal
- With knowledge and position comes responsibility
- How healthcare comms needs to adapt
- Hydroxychloroquine fails trial as preventative measure against COVID-19
PMHub
Skills in Healthcare
At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...
Latest intelligence
- AI and genomics: a revolution in drug discovery and development
- ...
- Working together against COVID-19
- Analysing social media conversations to see what HCPs are saying online about the global pandemic...
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
- Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Quick links
Infographics
